116 related articles for article (PubMed ID: 8546035)
1. Differences in eosinophil and neutrophil chemotactic responses in sowda and generalized form of onchocerciasis.
Rubio de Krömer MT; Medina-De la Garza CE; Brattig NW
Acta Trop; 1995 Sep; 60(1):21-33. PubMed ID: 8546035
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.
Bruijnzeel PL; Kuijper PH; Rihs S; Betz S; Warringa RA; Koenderman L
J Invest Dermatol; 1993 Feb; 100(2):137-42. PubMed ID: 8429236
[TBL] [Abstract][Full Text] [Related]
3. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda).
Gallin MY; Jacobi AB; Büttner DW; Schönberger O; Marti T; Erttmann KD
J Exp Med; 1995 Jul; 182(1):41-7. PubMed ID: 7790822
[TBL] [Abstract][Full Text] [Related]
4. Serum-dependent interaction of granulocytes with Onchocerca volvulus microfilariae in generalized and chronic hyper-reactive onchocerciasis and its modulation by diethylcarbamazine.
Medina-De la Garza CE; Brattig NW; Tischendorf FW; Jarrett JM
Trans R Soc Trop Med Hyg; 1990; 84(5):701-6. PubMed ID: 2278077
[TBL] [Abstract][Full Text] [Related]
5. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda).
Korten S; Wildenburg G; Darge K; Büttner DW
Acta Trop; 1998 Jun; 70(2):217-31. PubMed ID: 9698269
[TBL] [Abstract][Full Text] [Related]
6. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
7. The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda).
Hoerauf A; Kruse S; Brattig NW; Heinzmann A; Mueller-Myhsok B; Deichmann KA
Microbes Infect; 2002 Jan; 4(1):37-42. PubMed ID: 11825773
[TBL] [Abstract][Full Text] [Related]
8. Effect of terfenadine on neutrophil and eosinophil chemotactic activities after inhalation of platelet-activating factor in vivo and on neutrophil chemotaxis in vitro.
Okada C; Hopp RJ; Miyagawa H; Sugiyama H; Nair NM; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1992; 97(3):181-6. PubMed ID: 1587633
[TBL] [Abstract][Full Text] [Related]
9. Chemotactic responsiveness of eosinophils isolated from patients with inflammatory skin diseases.
Morita E; Schröder JM; Christophers E
J Dermatol; 1989 Oct; 16(5):348-51. PubMed ID: 2532224
[TBL] [Abstract][Full Text] [Related]
10. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
Rot A; Krieger M; Brunner T; Bischoff SC; Schall TJ; Dahinden CA
J Exp Med; 1992 Dec; 176(6):1489-95. PubMed ID: 1281207
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects.
Sehmi R; Cromwell O; Wardlaw AJ; Moqbel R; Kay AB
Clin Exp Allergy; 1993 Dec; 23(12):1027-36. PubMed ID: 10779297
[TBL] [Abstract][Full Text] [Related]
12. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
Håkansson L; Venge P
J Leukoc Biol; 1990 May; 47(5):449-56. PubMed ID: 2335754
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
15. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
Soyombo O; Spur BW; Lee TH
Allergy; 1994 Apr; 49(4):230-4. PubMed ID: 8037356
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
Morita E; Schröder JM; Christophers E
Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
[TBL] [Abstract][Full Text] [Related]
17. Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins.
Wildenburg G; Darge K; Knab J; Tischendorf FW; Bonow I; Büttner DW
Trop Med Parasitol; 1994 Jun; 45(2):87-96. PubMed ID: 7939167
[TBL] [Abstract][Full Text] [Related]
18. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
Turner NC; Wood LJ; Foster M; Gueremy T
Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
[TBL] [Abstract][Full Text] [Related]
19. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
20. Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma.
Håkansson L; Carlson M; Stålenheim G; Venge P
J Allergy Clin Immunol; 1990 Apr; 85(4):743-50. PubMed ID: 2324413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]